Targets 2008-2015

Targets 2008 - 2015

Novartis sets HSE targets covering periods of at least three years to allow better analysis, planning and implementation of programs. Progress towards targets is reviewed annually with each Division and Business Unit who are also involved in target setting based on recommendations by functional experts.
HSE performance data, as needed for management purposes as well as external reporting in line with international guidelines such as Global Reporting Initiative (GRI), are collected, validated and consolidated with the Novartis HSE Data Management System. Systems and processes are reviewed by third parties – in addition to Corporate and Divisional HSE audits – to ensure compliance with legal and Novartis HSE standards. Such processes support local sites in increasing the completeness and accuracy of their performance data.

For the coming years, the following targets have been defined on Group level:

• VOC halogenated: maintain 2007 target of 160 tons
• VOC non-halogenated: decrease to 1677 tons by 2008
• Hazardous Waste (organic) to Landfill: decrease to zero tons by 2008
• Energy efficiency improvement: 10% by 2010, based on 2006 data
• Contact water efficiency improvement: 10% by 2010, based on 2005 level
• CO₂ from Vehicles: decrease 10% by 2010, based on 2005 level
• Scope 1 GHG Emissions from Operations: decrease 5% below 1990 level by 2008–2012
• Lost Time Accident Rate: in 2008, the Lost-Time Accident Rate will be replaced by the Lost-Time Injury and Illness Rate (LTIR), a measure of employment-related injuries and illnesses ith lost time per 200 000 hours worked. The objective for 2008 is to reduce LTIR to 0.39.

Furthermore, the following goals are being pursued throughout the Group:

• Introduction of Behavior Based Safety Programs at all major Novartis sites by 2008
• Business Continuity Management Program fully implemented worldwide
• Risk reduction measures initiated and Business Continuity Plans established for all remaining risks (according to Risk Portfolios)
• Implementation and Testing of Pandemic Preparedness Program
• Novartis Emergency Management: Implementation of programs on Division/Business Unit levels as well as all smaller units.